2.

4.

3.

Mittal NK, Mandal B, Balabathula P, Lothstein L, Thoma LA, Wood GC. Formulation optimization and testing of CD22 targeted AD 198 loaded liposomes. Annual Mtg of the American Association of Pharmaceutical Scientists, 2014.

Mittal NK, Balabathula P, Mandal B, Lothstein L, Thoma LA Wood GC. Method development and validation of a fluorescence based assay for quantification of AD 198 in rat plasma.  Annual Mtg of the American Association of Pharmaceutical Scientists, 2013.

Mittal NK, Lothstein L, Wood GC, Mandal B, Balabathula P, Thoma LA. Comparison of cytotoxicity of CD22 targeted liposomal AD 198 with free AD 198 in CD22 vs Jurkat cells.  Annual Mtg of the American Association of Pharmaceutical Scientists, 2012.

Soberman JE, Brydon N, Lothstein KE, Lothstein L, Hofmann PA. Protection from ischemia-reperfusion injury by N-benzyladriamycin-14-valerate (AD 198). Proceedings of the 16th World Congress on Heart Disease, 2011.

 


1.

​​Innovative therapies
                         Superior outcomes